AccessibilityHelpAbout Us
Optimi Health logo

Optimi Health(NASDAQ) OPTH

Market Cap$27.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-71%
5 Year-67%
1 Year-19%
1 Month-3%
$4.84
-2.22%
-0.11Today
Optimi Health last closing stock price
MetricPriceDate
Last closeUSD 4.842026-09-21
Optimi Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.68%USD 4.762026-09-14
1 month-3.2%USD 5.002026-08-21
3 month+16.07%USD 4.172026-06-23
Year to date-29.36%USD 6.852025-12-31
1 year-19.33%USD 6.002025-09-19
3 year+11.26%USD 4.352023-09-22
5 year-66.53%USD 14.462021-09-22
Since inception-71.3%USD 16.872021-04-05

Optimi Health Financials at a Glance

Market Cap

$27.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$134.17K

Net Income (TTM)

-$6.19M

EPS (TTM)

-$0.93

P/E Ratio

-5.19

Dividend

$0.00

Beta (Volatility)

0.36 (Low)

Price

$4.84

Volume

85,898.063

Open

$4.99

Previous Close

$4.84

Daily Range

$4.75 - $4.99

52-Week Range

$4.00 - $8.84

Estimated Earnings Date

Feb 2, 2027

OPTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Optimi Health

Optimi Health Corp. is a Canadian company based in Princeton, focused on manufacturing pharmaceutical and nutraceutical products. Established in 2020, the company specializes in producing controlled substances, including MDMA and psilocybin, for authorized clinics and research trials.

Products and Services
  • Manufactures MDMA and psilocybin drug products
  • Offers functional mushrooms and dietary supplements
  • Supplies products through various channels, including Amazon
Growth Outlook
  • Expanding product portfolio to meet increasing demand in health and wellness
  • Strategic partnerships with clinics and research institutions enhance market reach
  • Focus on innovative research in psychedelic compounds for therapeutic use
Financial Highlights
  • Recent quarterly revenue of $98,700, showing potential for growth
  • Cash and cash equivalents of $9.2 million as of June 30, 2026
  • Operating expenses totaled $1.2 million, indicating investment in growth
Optimi Health Corp. operates in the rapidly evolving sector of psychedelic pharmaceuticals, which has garnered significant attention for its potential therapeutic benefits. The company's focus on controlled substances positions it well within a niche market that is gaining traction among healthcare providers and researchers. With a diverse product range and strategic partnerships, Optimi Health is poised for future growth as the demand for innovative health solutions continues to rise. The financial data reflects a commitment to expanding operations, despite current challenges in profitability. Investors may find interest in the company's long-term vision and its role in the emerging psychedelic industry.
AI Generated • Sep 11, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Dane Stevens

Website

www.optimihealth.ca

Headquarters

Princeton, BC V0X 1W0, CA

OPTH Financials

Key Financial Metrics (TTM)

Gross Margin

-2092.20%

Operating Margin

-3617.97%

Net Income Margin

-3927.59%

Return on Equity

-84.23%

Return on Capital

-34.18%

Return on Assets

-26.68%

Earnings Yield

-19.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.73M

Volume

85.90K

Avg. Volume

62.27K

Financials (TTM)

Gross Profit

-$938.00K

Operating Income

-$5.81M

EBITDA

-$4.36M

Operating Cash Flow

-$4.36M

Capital Expenditure

-$103.14K

Free Cash Flow

-$4.46M

Cash & ST Invst.

$9.20M

Total Debt

$3.62M

Optimi Health Performance Analysis

Optimi Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30USD 63,178N/A
20232023-09-30USD 134,260112.5%
20242024-09-30USD 286,483113.4%
20252025-09-30USD 304,9076.4%
Optimi Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-132.6%
Q12025-12-31100.0%
Q22026-03-31N/A
Q32026-06-30-0.8%
Optimi Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30USD -2.218.4%
20232023-09-30USD -1.33-40.0%
20242024-09-30USD -1.4911.9%
20252025-09-30USD -0.83-44.2%
Optimi Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-50.0%
Q12025-12-31-14.3%
Q22026-03-31-2.1%
Q32026-06-3020.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$98.70K

-49.7%

Gross Profit

-$298.70K

-264.2%

Gross Margin

-3.03%

N/A

Market Cap

$27.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$4.62M

N/A

Employees

6

N/A

Net Income

-$1.69M

-86.6%

EBITDA

-$1.34M

-134.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$9.20M

+10295.7%

Total Debt

$3.62M

+26.8%

Accounts Receivable

$34.83K

-86.3%

Inventory

$206.31K

-68.7%

Long Term Debt

$95.18K

-94.9%

Short Term Debt

$3.53M

+251.7%

Return on Assets

-26.68%

N/A

Return on Invested Capital

-35.76%

N/A

Free Cash Flow

-$2.02M

-135.7%

Operating Cash Flow

-$2.01M

-134.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
JSDAJones Soda Co.
$0.26-4.64%
CATWFChina Tontine Wines Group Limited
$0.07+0.00%
CTUNFClean Seas Seafood Limited
$0.08+0.00%
BRBMFBig Rock Brewery Inc.
$0.59-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
WBDWarner Bros. Discovery
$30.80+10.79%
GRMLGreenland Mines
$9.42+230.53%
INTCIntel
$121.78+12.14%
NVDANvidia
$227.38+2.30%

Questions About OPTH

What is the current price of Optimi Health?

Optimi Health is trading at $4.84 per share.

What is the 52-week range for Optimi Health?

Over the past 52 weeks, Optimi Health has traded between $4.00 and $8.84.

How much debt does Optimi Health have?

As of the most recent reporting period, Optimi Health reported total debt of $3.63M.

How much cash does Optimi Health have on hand?

Optimi Health reported $9.21M in cash and cash equivalents in its most recent financial results.

What is Optimi Health’s dividend yield?

Optimi Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services